Henoch-Schonlein Purpura in childhood: a tertiary care hospital experience in Turkey

Aysegul Bukulmez; Ecenur Dursun; Ayse Tolunay Oflu; Ayhan Pektas; Tolga A. Sen; Ahmet A. Tuncer; Kibriya Fidan

doi:10.18203/2349-3291.ijcp20181026

Authors

Aysegul Bukulmez Department of Pediatrics, Afyon Kocatepe University Medical Faculty, Afyonkarahisar, Turkey
Ecenur Dursun Department of Pediatrics, Afyon Kocatepe University Medical Faculty, Afyonkarahisar, Turkey
Ayse Tolunay Oflu Department of Pediatrics, Afyon Kocatepe University Medical Faculty, Afyonkarahisar, Turkey
Ayhan Pektas Department of Pediatrics, Afyon Kocatepe University Medical Faculty, Afyonkarahisar, Turkey
Tolga A. Sen Department of Pediatrics, Afyon Kocatepe University Medical Faculty, Afyonkarahisar, Turkey
Ahmet A. Tuncer Department of Pediatric Surgery, Afyon Kocatepe University Medical Faculty, Afyonkarahisar, Turkey
Kibriya Fidan Department of Pediatric Nephrology, Gazi University Medical Faculty, Ankara, Turkey

DOI:

https://doi.org/10.18203/2349-3291.ijcp20181026

Keywords:

Gastrointestinal tract, Henoch-Schönlein purpura, Renal involvement, Vasculitis

Abstract

Background: This study examines the clinical and laboratory features of children with Henoch-Schönlein purpura.

Methods: A retrospective study was applied for the 32 Henoch-Schönlein purpura patients who were monitored between January 2014 and June 2017 at the Pediatric clinic of a tertiary care hospital. The diagnoses were made based on the HSP criteria of the American College of Rheumatology. Age, gender, clinical and laboratory findings of the patients were recorded.

Results: The mean age of the 32 Henoch-Schönlein purpura patients was 9.29±3.29 years. Complaints at the time of admission were as follows: 93.8% of the patients (n=30) had rash; 40.6% (n=13) had abdominal pain; and 59.4% (n=19) had joint involvement and inability to walk. The results of fecal occult blood test examined during the admission were found as negative for the 75% (n=25) of patients and positive for the 19% (n=6) of patients. According to the urinary specimens, which were considered as the evidence of renal involvement at the applications, proteinuria was found negative for the 27 (8.4%) patients and positive for the 5 (1.6%) patients; hematuria was negative for the 29 (90.6%) children and positive for the 3 (%9.4) children. Antihistamine and non-steroidal anti-inflammatory were started as the treatment to the patients. During the follow-up, the 15.5% of patients had positive fecal blood tests although their test results were negative at the admission. During the clinical follow-up, the presence of proteinuria was found positive for the 6.3% of patients who had negative proteinuria test at their admissions.

Conclusions: Henoch-Schönlein purpura is a childhood vasculitis that manifests itself with rash and joint findings. It can cause significant complications due to gastrointestinal and genitourinary system involvement.

Metrics

Metrics Loading ...

References

Miller ML, Pachman LM. Vasculitis syndromes:Henoch-Schönlein purpura. In: Behrman RE, Kliegman RB, Jensen HB, eds. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: W.B. Saunders;2000:729.

Bagga A, Dillon MJ. Leukocytoclastic vasculitis. In: Cassidy JT, Petty RE, eds. Textbook of Pediatric Rheumatology. Philadelphia: W.B. Saunders;2001: 569-79.

Nielsen HE. Epidemiology of Schönlein Henoch purpura. Acta Pediatr Scand. 1988;77:125-31.

Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990;33:1114-21.

Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. Eular/Prınto/Pres criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69:798-806.

Ozcakar O, Fitoz S, Yalçınkaya F. Henoch Schonlein purpura. Klinik Gelişim Dergisi. 2006;19:52-5.

Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, et al. Clinical and path-ological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol. 2003;60:153-60.

Nuhoğlu Ç, Gedikoğlu H, Sonmez EO, Ozkozacı T, Ceran O. Retrospective analysis of demographic characteristics and laboratory findings of children with Henoch Schönlein purpura. Med J Haydarpaşa Numune Training Res Hospital. 2009;49:125-9.

Cakır M. Henoch-Schonlein purpura in North-Eastern Turkey. Ann Trop Paediatr. 2006;26:59-65.

Ersen A, Aydınoz S, Karademir F, Süleymanoğlu S, Meral C, Ozkaya H, et al. Henoch-Schonlein purpura of childhood: retrospective analysis of 42 cases. Dirim. 2009;84:35-41.

Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez Gay MA. Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum. 2002;32:149-56.

Inal A, Yılmaz M, Kendirli SG, Altıntaş DU, Karakoç GB, Doğruel D. The clinical Characteristics of Children with Henoch Schönlein Purpura. Erciyes Med J. 2009;31:153-61.

Bagga A, Kabra SK, Srivastava RN, Bhuyan UN. Henoch-Schönlein syndrome in Northern Indian children. Indian Pediatr. 1991;28:1153-7.

Jeong YK, Ha HK, Yoon CH, Gong G, Kim PN, Lee MG, et al. Gastrointestinal involvement in Henoch-Schonlein syndrome: CT findings. Am J Roentgenol. 1997;168:965-8.

Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in childhood with Henoch-Schönlein purpura. Pediatrics 1987;79:1018-21.

Koskimies O, Mir S, Rapola J, Viska J. Henoch- Schönlein nephritis: long term prognosis of unselected patients. Arch Dis Child. 1981;56:482-4.

Bayrakçı US, Topaloğlu R, Söylemezoğlu O, Kalyoncu M, Ozen S, Besbas N, et al. Effect of early corticosteroid therapy on development of Henoch-Schönlein nephritis. J Nephrol. 2007;20:406-9.